Supplementary Table 3 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma — Ken Dutton‐Regester | RDL Network
Ken Dutton‐Regester, Darryl Irwin, Priscilla Hunt, Lauren G. Aoude, Varsha Tembe, Gulietta M. Pupo, Cathy Lanagan, Candace D. Carter, Linda O'Connor, Michael F. O’Rourke, Richard A Scolyer, Graham J. Mann, Christopher Schmidt, Adrian C. Herington, Nicholas K. Hayward
Ken Dutton‐Regester, Darryl Irwin, Priscilla Hunt, Lauren G. Aoude, Varsha Tembe, Gulietta M. Pupo, Cathy Lanagan, Candace D. Carter, Linda O'Connor, Michael F. O’Rourke, Richard A Scolyer, Graham J. Mann, Christopher Schmidt, Adrian C. Herington, Nicholas K. Hayward
Ken Dutton‐Regester, Darryl Irwin, Priscilla Hunt, Lauren G. Aoude, Varsha Tembe, Gulietta M. Pupo, Cathy Lanagan, Candace D. Carter, Linda O'Connor, Michael F. O’Rourke, Richard A Scolyer, Graham J. Mann, Christopher Schmidt, Adrian C. Herington, Nicholas K. Hayward
Ken Dutton‐Regester, Darryl Irwin, Priscilla Hunt, Lauren G. Aoude, Varsha Tembe, Gulietta M. Pupo, Cathy Lanagan, Candace D. Carter, Linda O'Connor, Michael F. O’Rourke, Richard A Scolyer, Graham J. Mann, Christopher Schmidt, Adrian C. Herington, Nicholas K. Hayward
Ken Dutton‐Regester, Darryl Irwin, Priscilla Hunt, Lauren G. Aoude, Varsha Tembe, Gulietta M. Pupo, Cathy Lanagan, Candace D. Carter, Linda O'Connor, Michael F. O’Rourke, Richard A Scolyer, Graham J. Mann, Christopher Schmidt, Adrian C. Herington, Nicholas K. Hayward
Discussion(0)
No comments yet. Be the first to comment.